Published in Nucleic Acids Res on May 10, 1985
Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J Bacteriol (1987) 6.13
Role of iron in regulation of virulence genes. Clin Microbiol Rev (1993) 5.00
Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J (1986) 2.62
Differential regulation by iron of regA and toxA transcript accumulation in Pseudomonas aeruginosa. J Bacteriol (1989) 1.73
Characterization of the diphtheria tox transcript in Corynebacterium diphtheriae and Escherichia coli. J Bacteriol (1985) 1.49
Iron regulation of the cloned diphtheria toxin promoter in Escherichia coli. Infect Immun (1988) 1.48
Effect of iron on accumulation of exotoxin A-specific mRNA in Pseudomonas aeruginosa. J Bacteriol (1986) 1.44
Characterization of mutations that inactivate the diphtheria toxin repressor gene (dtxR). Infect Immun (1994) 1.38
D-Xylose (D-glucose) isomerase from Arthrobacter strain N.R.R.L. B3728. Gene cloning, sequence and expression. Biochem J (1991) 1.23
Evidence for direct regulation of diphtheria toxin gene transcription by an Fe2+-dependent DNA-binding repressor, DtoxR, in Corynebacterium diphtheriae. Infect Immun (1989) 1.22
Analysis of the diphtheria tox promoter by site-directed mutagenesis. J Bacteriol (1988) 1.19
Molecular cloning and nucleotide sequence of the Corynebacterium glutamicum pheA gene. J Bacteriol (1986) 1.15
High-level expression of a proteolytically sensitive diphtheria toxin fragment in Escherichia coli. J Bacteriol (1987) 1.01
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature (1984) 12.10
The nucleotide sequence of the initiation and termination sites for ribosomal RNA transcription in X. laevis. Cell (1979) 11.64
Unique features in the ribosome binding site sequence of the gram-positive Staphylococcus aureus beta-lactamase gene. J Biol Chem (1981) 11.17
Diphtheria toxin. Annu Rev Biochem (1977) 8.44
Protein-nucleic acid interactions in transcription: a molecular analysis. Annu Rev Biochem (1984) 8.31
Cascades of Sigma factors. Cell (1981) 7.58
Attenuation and processing of RNA from the rplJL--rpoBC transcription unit of Escherichia coli. Proc Natl Acad Sci U S A (1980) 3.86
Nucleotide sequence of the structural gene for diphtheria toxin carried by corynebacteriophage beta. Proc Natl Acad Sci U S A (1983) 3.79
Isolation and partial characterization of a corynebacteriophage beta, tox operator constitutive-like mutant lysogen of Corynebacterium diphtheriae. J Virol (1976) 3.55
Biosynthesis of hepatitis B virus surface antigen in Escherichia coli. Nature (1980) 3.00
Nucleotide sequence and expression of the diphtheria tox228 gene in Escherichia coli. Science (1983) 2.65
Synthesis of diphtheria tox-gene products in Escherichia coli extracts. Proc Natl Acad Sci U S A (1974) 2.62
The complete nucleotide sequence of the gene coding for diphtheria toxin in the corynephage omega (tox+) genome. Nucleic Acids Res (1983) 2.51
Evidence that the regulation of diphtheria toxin production is directed at the level of transcription. J Bacteriol (1978) 2.34
Cloned fragment A of diphtheria toxin is expressed and secreted into the periplasmic space of Escherichia coli K12. Science (1983) 1.60
The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197. Nucleic Acids Res (1984) 1.60
Diphtheria toxin and related proteins. 3. Reconstitution of hybrid "diphtheria toxin" from nontoxic mutant proteins. J Biol Chem (1973) 1.55
Regulation of toxinogenesis in Corynebacterium diphtheriae. II. Genetic mapping of a tox regulatory mutation in bacteriophage beta. J Virol (1981) 0.99
Mutants of Corynebacterium diphtheriae PW8 that produce toxin in medium with excess iron. Appl Environ Microbiol (1981) 0.90
Human papillomavirus infection requires cell surface heparan sulfate. J Virol (2001) 3.32
Nucleotide sequence and expression of the diphtheria tox228 gene in Escherichia coli. Science (1983) 2.65
Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol (2000) 2.62
Characterization of cDNA coding for human factor XIIIa. Proc Natl Acad Sci U S A (1986) 2.62
Nucleotide sequence of the invasion plasmid antigen B and C genes (ipaB and ipaC) of Shigella flexneri. Microb Pathog (1988) 2.43
The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology (1991) 2.36
Molecular strategy for 'serotyping' of human enteroviruses. J Gen Virol (2001) 2.33
Generation and neutralization of pseudovirions of human papillomavirus type 33. J Virol (1997) 2.29
Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J Virol (1986) 2.20
Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J (1995) 2.05
Nucleotide sequence of a cluster of early and late genes in a conserved segment of the vaccinia virus genome. Nucleic Acids Res (1985) 2.02
Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci U S A (1984) 2.00
Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology (1994) 1.89
Patchwork structure of a bovine satellite DNA. Cell (1979) 1.77
Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees. J Virol (2001) 1.75
Defined fragments of calf, human, and rat DNA produced by restriction nucleases. Eur J Biochem (1974) 1.73
Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol (1995) 1.70
Single-strand and double-strand cleavage at half-modified and fully modified recognition sites for the restriction nucleases Sau3a and Taqi. Gene (1980) 1.63
Closely spaced nucleosome cores in reconstituted histone.DNA complexes and histone-H1-depleted chromatin. Eur J Biochem (1978) 1.62
Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines. J Virol (1998) 1.52
High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol (1994) 1.52
Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol (2000) 1.50
Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation. Biochemistry (1979) 1.49
Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. J Gen Virol (1995) 1.48
Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol (1993) 1.45
gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains. J Virol (1991) 1.45
Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. J Gen Virol (1994) 1.44
The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigens. J Virol (1986) 1.41
Immunological analyses of human papillomavirus capsids. Vaccine (2001) 1.40
New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol Pharmacol (2000) 1.32
Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus. J Gen Virol (1995) 1.30
A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles. Science (1986) 1.30
Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins. J Virol (1991) 1.29
Poliovirus induces apoptosis in the mouse central nervous system. J Virol (1999) 1.27
A long-range and two short-range periodicities are superimposed in the 1.706-g/cm3 satellite DNA from calf thymus. Eur J Biochem (1978) 1.25
A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J Virol (1993) 1.25
Mapping of cleavage sites for restriction endonucleases in lambdadv plasmids. Eur J Biochem (1975) 1.23
Evidence for direct regulation of diphtheria toxin gene transcription by an Fe2+-dependent DNA-binding repressor, DtoxR, in Corynebacterium diphtheriae. Infect Immun (1989) 1.22
Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology (1995) 1.21
Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope. Nat Struct Biol (1995) 1.20
Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J Virol (1997) 1.19
Cleavage of small bacteriophage and plasmid DNAs by restriction endonucleases. Eur J Biochem (1974) 1.16
Complete cDNA sequence encoding human beta-galactoside alpha-2,6-sialyltransferase. Nucleic Acids Res (1990) 1.12
Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33. J Virol (1993) 1.11
Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J Virol (1996) 1.11
Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid protein L2. J Gen Virol (1995) 1.11
Phosphorylation of dephosphorylated tRNA and oligonucleotides by polynucleotide kinase. Biochim Biophys Acta (1970) 1.09
Genome organization and nucleotide sequence of human papillomavirus type 39. Virology (1991) 1.07
Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage. Euro Surveill (2010) 1.05
The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J (1989) 1.04
Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. J Clin Invest (1990) 1.02
Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles. J Virol (1992) 1.01
Chromatin diminution in Ascaris suum: nucleotide sequence of the eliminated satellite DNA. Nucleic Acids Res (1982) 1.00
Investigation of the repetitive sequences in calf DNA by cleavage with restriction nucleases. Eur J Biochem (1975) 1.00
Nucleosome formation abolishes base-specific binding of histones. Nature (1975) 1.00
Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 2. Reactivation of irreversibly denatured aggregates. Biochemistry (1979) 1.00
Induction of type-specific neutralizing antibodies by capsomeres of human papillomavirus type 33. Virology (2001) 1.00
Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity. Oncogene (1999) 1.00
Insertions in the hepatitis B surface antigen. Effect on assembly and secretion of 22-nm particles from mammalian cells. J Mol Biol (1987) 0.98
Isolation of overproducing recombinant mammalian cell lines by a fast and simple selection procedure. Gene (1988) 0.98
Prototype sequence of bovine 1.720 satellite DNA. J Mol Biol (1980) 0.97
Inserted sequences in bovine satellite DNA's. Science (1981) 0.96
Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity. Eur J Biochem (2001) 0.96
A multicopy insertion sequence in the bovine genome with structural homology to the long terminal repeats of retroviruses. Nature (1982) 0.94
Continuous production of Rous sarcoma virus free of transformation defective virus in clones of established RSV-transformed quail cells. Virology (1981) 0.93
The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses. Cytotechnology (1999) 0.92
Analysis of intermolecular disulfide bonds and free sulfhydryl groups in hepatitis B surface antigen particles. Arch Virol (1997) 0.92
Presentation and immunogenicity of the hepatitis B surface antigen and a poliovirus neutralization antigen on mixed empty envelope particles. J Virol (1988) 0.91
Enhancement of gene expression by somatic hybridization with primary cells: high-level synthesis of the hepatitis B surface antigen in monkey Vero cells by fusion with primary hepatocytes. Biotechnology (N Y) (1990) 0.91
An expression vector for high-level protein synthesis in Vero cells. Gene (1989) 0.91
Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus. J Virol (1995) 0.91
Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction. Vaccine (1994) 0.90
Characterization of the native and denatured conformations of tRNA Ser and tRNA Phe from yeast. Eur J Biochem (1972) 0.90
Heterogeneity of recombinant human antithrombin III expressed in baby hamster kidney cells. Effect of glycosylation differences on heparin binding and structure. J Biol Chem (1993) 0.89
Rate-determining folding and association reactions on the reconstitution pathway of porcine skeletal muscle lactic dehydrogenase after denaturation by guanidine hydrochloride. Biochemistry (1982) 0.89
Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells. J Neurovirol (1998) 0.88
Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity. Arch Biochem Biophys (1997) 0.88
Synthesis, properties and applications of papillomavirus-like particles. Intervirology (1996) 0.85
Isolation of cis-acting vaccinia virus DNA fragments promoting the expression of herpes simplex virus thymidine kinase by recombinant viruses. J Virol (1985) 0.83
Reconstituted histone--DNA complexes. Philos Trans R Soc Lond B Biol Sci (1978) 0.83
Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania. Arch Virol (2007) 0.83
Expression of a biologically active diphtheria toxin fragment B in Escherichia coli. Mol Microbiol (1988) 0.83
Denaturation-renaturation of the fibrin-stabilizing factor XIII a-chain isolated from human placenta. Properties of the native and reconstituted protein. Biol Chem Hoppe Seyler (1990) 0.82
Obtaining a functional recombinant anti-rhesus (D) antibody using the baculovirus-insect cell expression system. Immunology (1997) 0.82
Is there a neutralization epitope in the second conserved domain of HIV-1 envelope protein? AIDS Res Hum Retroviruses (1991) 0.82
HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins. AIDS Res Hum Retroviruses (1992) 0.81
Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes. J Gen Virol (1995) 0.81
Reconstitution of lactic dehydrogenase after acid dissociation. The yield of reactivation is determined by conformational rearrangements of the dissociated monomers. Eur J Biochem (1981) 0.81
Isolation, physicochemical properties, and folding of octopine dehydrogenase from Pecten jacobaeus. Eur J Biochem (1984) 0.81
Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation. Biochem J (1992) 0.81
An alternative procedure for the strand separation of DNA fragments. FEBS Lett (1981) 0.80
Amplifiable expression vectors for mammalian cell lines. Gene (1987) 0.80
Thermostabilization of live virus vaccines by heavy water (D2O). Vaccine (1995) 0.80
Cassette baculovirus vectors for the production of chimeric, humanized, or human antibodies in insect cells. Eur J Immunol (1995) 0.80